Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways
Xiaolan Lian(Beth Israel Deaconess Medical Center), Yuanzhong Chen(Fujian Medical University)
Cited by 33
Related Papers
Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells
|Nature Communications|2018|161
Bone marrow stromal cells protect acute myeloid leukemia cells from anti‐CD44 therapy partly through regulating PI3K/Akt–p27<sup>Kip1</sup> axis
|Molecular Carcinogenesis|2014|53
TCP1 increases drug resistance in acute myeloid leukemia by suppressing autophagy via activating AKT/mTOR signaling
|Cell Death and Disease|2021|34